by studies both invivo (7, 9, 15, 18, 27, 28) and in the perfused heart preparation ( 10, 22, 29) that free fatty acids (FFA) are an important substrate for myocardial metabolism. Skeletal muscle has also been shown to oxidize FFA ( 1, 12, 13, 24, 3 1, 32) . Evidence obtained in dogs (4, 5, 33) , in man (7), in the perfused rat heart (16, 25, 34) , and in the rat diaphragm incubated in vitro (24) has demonstrated that ketone bodies are readily metabolized by the myocardium and skeletal muscle, Furthermore, Williamson and Krebs (34) , Hall ( 16) , and Olson (25) have shown that acetoacetate (AcAc) is oxidized in preference to FFA by the isolated perfused heart; however, little is known about competition between FFA and ketone bodies for metabolism by the heart or skeletal muscle under in vivo conditions.
Bassenge and his co-workers (5) observed an increase in the respiratory quotient of the heart and a decrease in the removal of FFA when AcAc was infused into intact dogs; however, no direct measurement of FFA oxidation was reported. The present investigation was undertaken to study the relationship between ketone body and FFA uptake by the dog heart and skeletal muscle in vivo with particular emphasis on a possible effect of ketone bodies on FFA oxidation by these tissues. The experiments were designed to measure the blood flow and the uptake of P-hydroxybutyrate (P-OHB), AcAc, and FFA by both myocardium and thigh skeletal muscle in the same dogs, under control conditions, and during an intravenous infusion of Na dl-P-hydroxybutyrate. The remainder of each sample was centrifuged in a refrigerated centrifuge and two aliquots of plasma, each of 1 ml, were added to 20 ml of chloroformmethanol mixture, 2: I parts by volume ( 11) to extract the lipids.
The major lipid classes were separated by thin-layer chromatography using plates coated with silica gel-G (Merck) of 0.25-mm thickness impregnated with 0.02 % 2'7'-dichlorofluorescein.
The plates were developed in hexane-diethyl ether-glacial acetic acid, 156 : 40 : 4 parts by volume (2 I). The FFA spot (and in 5 dogs also the triglyceride spot) was scraped from the first chromatograph of each sample, placed in a counting vial, 10 ml of Bray's solution added, and each vial counted in a Packard liquid scintillation spectrometer* Radioactivity was expressed as disintegrations per minute, after allowing for quenching and counting efficiency. The FFA spot from the second chromatograph of each sample was removed, placed in an 80-ml tube, and methylation was carried out by the addition of 5 ml of methanol, 0.1 ml of Z-2dimethoxypropane, and 0.2 ml of concentrated sulfuric acid, followed by incubation overnight in a 40 C water bath. Samples (5 ~1 each) of the methylated fatty acids were chrornatographed using a Barber-Colman gas-liquid chromatograph equipped with a glass column (x inch by 6 ft) packed with diethylene glycol succinate polyester (Applied Science Laboratories). The operating conditions were as follows: the column temperature 185 C; temperature of strontium ionization detector 250 C; rate of flow of the carrier argon, 80 ml/min. The samples were quantitated by the use of hcptadecanoic acid as an internal standard, and the area under the peaks was expressed as a product of width at half-height multiplied by peak height to obtain the concentrations of the individual fatty acids, these were then added to give the total plasma FFA content.
The blood samples for carbon dioxide determinations were taken as previously described (3 1 The Na dl-P-hydroxybutyrate infusion lowered arterial FFA and total-body turnover of FFA (Table 3) : the arterial 38.3 =t 2.3 FFAJ4C radioactivity did not change significantly so that the FFA-14C specific activity was increased. 
RESULTS
The mean coronary sinus and profunda fernoris blood flows before and during infusion of Na dZ-+hydroxybutyrate are presented in Table  1 . No significant change in the flow values or in the hematocrit occurred due to the ketone body infusion.
Because the saturation method used expresses mvocardial blood flow per 100 g of tissue, the metabolic'data can be related to a weight of myocardial tissue. The direct flow determination in the case of the profunda femoris veins did not allow a similar computation for skeletal muscle. in skeletal muscle this parameter decreased significantly (-98 + 35 dpm/ml) in six dogs, whereas in the remaining animal it was substantially increased so that the mean difference shown in Table 4 was not significant. The data relating to the formation of 14C02 are shown in Table  5 . The coronary sinus 14C02 radioactivity was higher than that of arterial blood both before and during the infusion; however, the increase was significantly reduced during the infusion. The 14C02 specific activity of coronary sinus blood was significantly higher than that of arterial blood both before (29.1 =t 4.8 dpm/pmole and during (9.9 & 1.8 dpm/pmole) the infusion, and this difference was also significantly lowered during the infusion. Thus, the production of 14CO:! by the myocardium was significantly lowered during the infusion of the ketone. Although there was an increase in the radioactivity of the profunda femoris venous blood before and during the infusion, the PF-A 14COz specific activity values were not significantly different from zero either before ( I. 11 & 0.82 dpm/pmole), or during ( 1.57 & 0.91 dpm/pmole) the infusion. A summary of FFA metabolism by the myocardium is given in Table  6 . Infusion of Na dl-P-hydroxybutyrate resulted in a marked decrease in the rate of uptake of FFA and FFA oxidation, both parameters being reduced by 58 % of the control value. The release of FFA as shown by the mean values amounted to about one-third of the FFA uptake; no significant change in the FFA release could be demonstrated during the ketone body infusion. Table 7 contains information relating to the metabolism of FFA by skeletal muscle. Although the reduction in the mean uptake of FFA during the infusion of Na dl-P-hydroxybutyrate was not statistically significant, a lowered uptake was observed in six of the seven dogs. Ln contrast to the myocardium, the release of FFA from the skeletal muscle area exceeded the uptake, both before and during the exogenous hydroxybutyrate infusion, and furthermore, this release was significantly reduced when the circulating ketone concentration was elevated. Radioactive triglyceride fatty acids were measured on the control samples from five dogs, and the results are shown in Table 8 . It was found that both myocardium and skeletal muscle extracted about 6 % of the arterial labeled TGFA.
DFSCUSSION
The results of this study show that elevation of the circulating concentrations of P-OHB and AcAc resulted in a decrease in the rate of FFA uptake and oxidation by dog myocardium.
A parallel effect was observed in the case of skeletal muscle in six of seven dogs. The decrease in the arterial FFA concentration that occurred when the blood ketone body concentrations were raised was probably due to the stimulatory effect ketone bodies have been shown to exert on insulin secretion (ZO), although a direct action on adipose tissue reducing fatty acid release may also have been operative (8). The fact that the myocardial uptake of FFA has been shown to decrease with lowered arterial FFA levels (9, 28) makes it possible that the depression of the circulating level of FFA found in the present study contributed to the reduced FFA uptake that accompanied elevation of the blood ketone concentrations. It has already been mentioned that the plasma FFAJ4C specific activity in both the coronary sinus and the profunda femoris veins was considerably lower than that of the arterial plasma. There are at least three possible ex- fatty acids resulting from the extraction of TGFA-14C were released into the profunda femoris blood, dilution of the specific activity of the venous blood to 6,300 dpm/pmole would occur, whereas the measured FFA-14C specific activity of the profunda femoris blood was 2,741 dpm/ pmole, indicating release of unlabeled fatty acids also took place across skeletal muscle. Therefore, it would seem that the decrease in the FFA-14C specific activity was due to the release of unlabeled fatty acids, both in the case of dog myocardium and skeletal muscle. A similar view has recently been expressed concerning the human myocardium by Most and his co-workers (23). The precise cellular origin of the released fatty acids is not known. It is likely, ketone concentrations during @-OHB infusion were 1.290 and 1.414 prnoles ,&OHB/ml of blood and 0.434 and 0.459 ~rnoles AcAc/ml of blood. The venous concentrations of these metabolites were equally constant during the experiments.
The present results show that, at elevated blood concentrations, P-OHB and AcAc become important substrates for dog myocardium, emphasizing under in vivo conditions, the point previously made by workers ( 16, 25, 34) using the perfused heart in vitro. If the ketone bodies taken up by the myocardium were completely oxidized they could account for 83% of the myocardial CO2 production as is shown in Table  9 . In skeletal muscle, the corresponding value exceeded 100 %; the reason for this high value is not clear from the present data. Table 9 also shows that under control conditions, FFA oxidation accounted for 65 7G of the CO2 production by the myocardium; however, during the infusion, when the blood ketone levels were elevated, the contribution of FFA fell to 28 o/o so that ketones prob-
